Literature DB >> 11384665

Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.

S A Stanilova1, E S Slavov.   

Abstract

The assessment of the soluble immune complexes (IC) in human sera is traditionally performed by the C1q binding assay. In the present study, a novel method for the quantity of immune complexes was reported. The methodology was based on measuring their deposition on solid-phase C3 binding glycoprotein (CIF), using an enzyme-linked immunosorbent assay. We also used ELISA that employed anti-C3 antibodies to determined the quantity of immune complexes. The three assays were evaluated for their performance characteristics on the same specially prepared samples: 55 normal sera, 99 sera from RA, 88 sera from SLE, and 27 sera from PSS. The results were compared by reference to a common standard-heat aggregated IgG that possesses many activities of immune complexes. Three of the tests used displayed almost the same specificity (over 95%), while their relative sensitivity varied depending on the disease sera tested. The sensitivity of the assays used was recorded highest for C1q ELISA-28.97% of positive sera, followed by CIF-ELISA-19.63% and lowest for anti-C3 ELISA-17.29%. A well-expressed correlation was found between CIF-ELISA and anti-C3 ELISA data (r=0.42), and a week correlation was noted when comparing CIF-ELISA and C1q ELISA IC levels detected (r=0.28). When the correlation coefficients were calculated individually for each disease category, they were clearly different, and that reflected indirectly in different sensitivities of the test for various disease categories. We also found that the results from the simultaneous performance of the tests demonstrated low percentage positive results when three or two assays were used. This is most probably due to the different assay abilities to detect IC with different sizes and composition, which shows that a small part of IC in the tested sera can be detected simultaneously by more than one assay. On the basis of the results obtained, we concluded that optimal screening for IC could be achieved by parallel application of several different methods.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384665     DOI: 10.1016/s0022-1759(01)00370-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.

Authors:  Daniel Chargelegue; Pascal M W Drake; Patricia Obregon; Alessandra Prada; Neil Fairweather; Julian K-C Ma
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis.

Authors:  Prakash Senbagavalli; Rajamanickam Anuradha; Vadakkuppattu D Ramanathan; Vasanthapuram Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus.

Authors:  Ana Henriques; Luís Inês; Tiago Carvalheiro; Maura Couto; Angela Andrade; Susana Pedreiro; Paula Laranjeira; José Mário Morgado; Maria Luísa Pais; José António Pereira da Silva; Artur Paiva
Journal:  Rheumatol Int       Date:  2011-01-08       Impact factor: 2.631

4.  Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjögren's syndrome A antibodies.

Authors:  L Mathsson; E Ahlin; C Sjöwall; T Skogh; J Rönnelid
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  New insights into intra- and intermolecular interactions of immunoglobulins: crystal structure of mouse IgG2b-Fc at 2.1-A resolution.

Authors:  Petr Kolenko; Jan Dohnálek; Jarmila Dusková; Tereza Skálová; Renata Collard; Jindrich Hasek
Journal:  Immunology       Date:  2008-09-06       Impact factor: 7.397

6.  Rat C-reactive protein activates the autologous complement system.

Authors:  Niubel Diaz Padilla; Wim K Bleeker; Yvonne Lubbers; Gemma M M Rigter; Gerard J Van Mierlo; Mohamed R Daha; C Erik Hack
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

7.  Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients.

Authors:  Ketil Moen; Johan G Brun; Tor Magne Madland; Turid Tynning; Roland Jonsson
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

8.  Estimation of Circulating Immune Complexes in patients with Oral Leukoplakia and Oral Submucous Fibrosis: A Case Control Study.

Authors:  Maheswari H; Eswaran M A; Srividhya S; Malavika R; Prabhu R; Geetha K R
Journal:  J Clin Diagn Res       Date:  2014-01-12

9.  In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations.

Authors:  F Dhainaut; P-O Guillaumat; H Dib; G Perret; A Sauger; C de Coupade; M Beaudet; M Elzaabi; L Mouthon
Journal:  Vox Sang       Date:  2012-09-25       Impact factor: 2.144

Review 10.  Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

Authors:  Philip J Budge; Carly Herbert; Britt J Andersen; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2018-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.